It's the latest evidence of rising spending in the drug discount program as regulators attempt to tamp down on growth in 340B.
Source: Healthcare Dive
You may also like
Trump’s CDC Nominee Praises Vaccines, Without Vowing...
Watch: ‘Robust’ Primary Care, Transparency Top...
Insurers Hedge on Trump-Backed Pledge To Improve...
Large funding rounds help boost digital health...
Medtronic completes SPR Therapeutics acquisition
Abbott discloses cyberattack on cancer diagnostics...
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.